keyword
https://read.qxmd.com/read/38549238/adherence-to-glp1-ra-and-sglt2-i-affects-clinical-outcomes-and-costs-in-patients-with-type-2-diabetes
#21
JOURNAL ARTICLE
Stefano Ciardullo, Laura Savaré, Federico Rea, Gianluca Perseghin, Giovanni Corrao
AIMS: To evaluate the impact of adherence to glucagon like peptide-1 receptor agonists (GLP1-RA) and sodium-glucose transporter two inhibitors (SGLT2-I) on clinical outcomes and costs in patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: The 121,115 residents of the Lombardy Region (Italy) aged ≥40 years newly treated with metformin during 2007-2015 were followed to identify those who started therapy with GLP1-RA or SGLT2-I. Adherence to drug therapy over the first year was defined as the proportion of days covered >80%...
May 2024: Diabetes/metabolism Research and Reviews
https://read.qxmd.com/read/38548175/use-of-sglt-inhibitors-in-type-1-diabetes-the-promise-and-the-perils
#22
REVIEW
Patricia R Peter, Silvio E Inzucchi
OBJECTIVE: Despite improvements in glucose monitoring technologies, insulin formulations and insulin delivery systems, too many patients with type 1 diabetes continue to struggle to meet their glycemic goals. As a result, they suffer from high rates of microvascular and macrovascular disease. Titration of insulin therapy, while essential to the care of these patients, is often limited by undesirable side effects of hypoglycemia and weight gain. SGLT inhibitors have been proposed as a potential adjunctive therapy to insulin that may offset some of these effects, while simultaneously enabling patients with type 1 diabetes to potentially reap the cardiovascular and renal benefits afforded by these agents in those with type 2 diabetes...
March 26, 2024: Endocrine Practice
https://read.qxmd.com/read/38548108/effects-of-long-term-hba1c-variability-on-serious-infection-risks-in-patients-with-type-2-diabetes-and-the-influence-of-age-sex-and-ethnicity-a-cohort-study-of-primary-care-data
#23
JOURNAL ARTICLE
Iain M Carey, Julia A Critchley, Umar A R Chaudhry, Derek G Cook, Stephen DeWilde, Elizabeth S Limb, Liza Bowen, Stephen Woolford, Peter H Whincup, Naveed Sattar, Arshia Panahloo, Tess Harris
AIMS: Long-term HbA1c (glycated haemoglobin) variability is associated with micro- and macrovascular complications in Type 2 diabetes (T2D). We explored prospective associations between HbA1c variability and serious infections, and how these vary by HbA1c level, age, sex and ethnicity. METHODS: 411,963 T2D patients in England, aged 18-90, alive on 01/01/2015 in the Clinical Practice Research Datalink with ≥ 4 HbA1c measurements during 2011-14...
March 26, 2024: Diabetes Research and Clinical Practice
https://read.qxmd.com/read/38541098/physicians-practices-in-diabetic-nephropathy-in-primary-healthcare-centers-in-jazan-city-saudi-arabia-2023
#24
JOURNAL ARTICLE
Amal J Alfaifi, Ahmed Y Abdaly, Bashaer M Ghazwani, Ibrahim M Gosadi
Background and Objectives : Diabetes is one of the most common diseases dealt with by physicians in primary healthcare centers (PHCs). The disease is associated with macrovascular and microvascular complications, especially in those with long disease duration and uncontrolled diabetic nephropathy, which is one of the most common microvascular complications among diabetic patients. This investigation assessed the practices of physicians working at PHCs in terms of diabetic nephropathy screening, management, and referral...
February 22, 2024: Medicina
https://read.qxmd.com/read/38539811/genetic-and-transcriptomic-background-of-oxidative-stress-and-antioxidative-therapies-in-late-complications-of-type-2-diabetes-mellitus-a-systematic-review
#25
REVIEW
Gašper Tonin, Vita Dolžan, Jasna Klen
This systematic review extensively investigated the role of the genetic and transcriptomic factors in late complications of type 2 diabetes mellitus (T2DM) and the current approaches targeting oxidative-stress-related pathways with antioxidant therapies. To cover our broad research area, we have conducted two systematic searches, the first focusing on genetic and transcriptomic factors affecting oxidative stress and the second one focusing on the antioxidant therapies in late complications of T2DM. The final review included 33 genetic and transcriptomic studies and 23 interventional randomized clinical trials...
February 24, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38535332/association-between-protein-intake-and-diabetes-complications-risk-following-incident-type-2-diabetes-the-epic-potsdam-study
#26
JOURNAL ARTICLE
Elif Inan-Eroglu, Olga Kuxhaus, Franziska Jannasch, Daniela V Nickel, Matthias B Schulze
Our knowledge about the connection between protein intake and diabetes-related complications comes largely from studies among those already diagnosed with type 2 diabetes (T2D). However, there is a lack of information on whether changing protein intake after diabetes diagnosis affects complications risk. We aimed to explore the association between protein intake (total, animal, and plant) and vascular complications in incident T2D patients considering pre-diagnosis intake and changes in intake after diagnosis...
March 19, 2024: Metabolites
https://read.qxmd.com/read/38530352/wait-times-for-scheduling-appointments-for-prevention-of-macrovascular-and-microvascular-complications-of-diabetes-cross-sectional-descriptive-study
#27
JOURNAL ARTICLE
Corey H Basch, Grace C Hillyer, Charles E Basch
BACKGROUND: Diabetes is a chronic disease that requires lifelong management and care, affecting around 422 million people worldwide and roughly 37 million in the United States. Patients newly diagnosed with diabetes must work with health care providers to formulate a management plan, including lifestyle modifications and regular office visits, to improve metabolic control, prevent or delay complications, optimize quality of life, and promote well-being. OBJECTIVE: Our aim is to investigate one component of system-wide access to timely health care for people with diabetes in New York City (NYC), namely the length of time for someone with newly diagnosed diabetes to obtain an appointment with 3 diabetes care specialists: a cardiologist, an endocrinologist, and an ophthalmologist, respectively...
March 26, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38517436/enrollment-in-high-deductible-health-plans-and-incident-diabetes-complications
#28
JOURNAL ARTICLE
Rozalina G McCoy, Kavya S Swarna, David H Jiang, Holly K Van Houten, Jie Chen, Esa M Davis, Jeph Herrin
IMPORTANCE: Preventing diabetes complications requires monitoring and control of hyperglycemia and cardiovascular risk factors. Switching to high-deductible health plans (HDHPs) has been shown to hinder aspects of diabetes care; however, the association of HDHP enrollment with microvascular and macrovascular diabetes complications is unknown. OBJECTIVE: To examine the association between an employer-required switch to an HDHP and incident complications of diabetes...
March 4, 2024: JAMA Network Open
https://read.qxmd.com/read/38510674/chronic-ocular-small-vessel-disease-an-overview-of-diabetic-retinopathy-and-its-relationship-with-cardiovascular-health
#29
JOURNAL ARTICLE
Siva S R Iyer, Nila S Radhakrishnan, Ramak Roohipourmoallai, Cynthia M Guerin, Jeremy S Maylath, Nickolas Garson
Diabetic retinopathy (DR) is a potentially blinding disease originating from small vessel damage in the retina in chronic hyperglycemic states. DR has a complex multi-pathway driven pathogenesis resulting in diabetic macular edema and retinal ischemia, the former being the most common cause of vision impairment in DR. Hypoxia induced cytokines stimulate vascular endothelial growth factor (VEGF) production and subsequent angiogenesis with resultant mechanical retinal damage over time. Anti-VEGF therapy is effective for the treatment of center-involving diabetic macular edema...
May 2023: American heart journal plus: cardiology research and practice
https://read.qxmd.com/read/38504754/a-multi-centre-investigation-of-macrovascular-and-non-ocular-microvascular-complications-in-children-and-adolescents-with-diabetes-mellitus-in-southern-ghana
#30
JOURNAL ARTICLE
Josephine Akpalu, Vera A Essuman, Winfried M Amoaku, Benjamin Abaidoo, Akye Essuman, Charles Hayfron-Benjamin, Nana A Barnes, Naa N Tagoe, George Asare, Thomas A Ndanu, Benedicta Appiah-Thompson, Imelda D-B Ofori-Adjei, Adziri H Sackey
OBJECTIVES: To investigate the prevalence of macrovascular and non-ocular microvascular complications and the associated factors among children and adolescents with diabetes mellitus in selected hospitals in southern Ghana. DESIGN: A cross-sectional study. SETTING: The out-patient clinics of the Departments of Child Health, Medicine and Therapeutics, Family Medicine, Ophthalmology, and the National Diabetes Management and Research Centre, all at the Korle Bu Teaching Hospital, Accra, as well as from Cape-Coast Teaching Hospital in the Central Region of Ghana...
June 2023: Ghana Medical Journal
https://read.qxmd.com/read/38495794/early-effective-intervention-can-significantly-reduce-all-cause-mortality-in-prediabetic-patients-a-systematic-review-and-meta-analysis-based-on-high-quality-clinical-studies
#31
Xuedong An, Yuehong Zhang, Wenjie Sun, Xiaomin Kang, Hangyu Ji, Yuting Sun, Linlin Jiang, Xuefei Zhao, Qing Gao, Fengmei Lian, Xiaolin Tong
BACKGROUND: Reducing the occurrence of diabetes is considered a primary criterion for evaluating the effectiveness of interventions for prediabetes. There is existing evidence that early lifestyle-based interventions can significantly decrease the incidence of diabetes. However, whether effective interventions can reduce long-term outcomes in patients, including all-cause mortality, cardiovascular risks, and the occurrence of microvascular complications, which are the most concerning issues for both patients and clinicians, remains a subject of inconsistent research findings...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38493952/major-adverse-events-in-youth-onset-type-1-and-type-2-diabetes-the-search-and-today-studies
#32
JOURNAL ARTICLE
Amy K Mottl, Jeanie B Tryggestad, Scott Isom, Rose A Gubitosi-Klug, Leora Henkin, Neil H White, Ralph D'Agostino, Kara S Hughan, Lawrence M Dolan, Kimberly L Drews
AIMS: To determine contemporary incidence rates and risk factors for major adverse events in youth-onset T1D and T2D. METHODS: Participant interviews were conducted once during in-person visits from 2018-2019 in SEARCH (T1D: N=564; T2D: N=149) and semi-annually from 2014-2020 in TODAY (T2D: N=495). Outcomes were adjudicated using harmonized, predetermined, standardized criteria. RESULTS: Incidence rates (events per 10,000 person-years) among T1D participants were: 10...
March 15, 2024: Diabetes Research and Clinical Practice
https://read.qxmd.com/read/38474219/new-insights-into-endothelial-dysfunction-in-cardiometabolic-diseases-potential-mechanisms-and-clinical-implications
#33
REVIEW
Giovanna Gallo, Carmine Savoia
The endothelium is a monocellular layer covering the inner surface of blood vessels. It maintains vascular homeostasis regulating vascular tone and permeability and exerts anti-inflammatory, antioxidant, anti-proliferative, and anti-thrombotic functions. When the endothelium is exposed to detrimental stimuli including hyperglycemia, hyperlipidemia, and neurohormonal imbalance, different biological pathways are activated leading to oxidative stress, endothelial dysfunction, increased secretion of adipokines, cytokines, endothelin-1, and fibroblast growth factor, and reduced nitric oxide production, leading eventually to a loss of integrity...
March 4, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38471431/association-between-obstructive-coronary-disease-and-diabetic-retinopathy-cross-sectional-study-of-coronary-angiotomography-and-multimodal-retinal-imaging
#34
JOURNAL ARTICLE
Andre Chateaubriand Campos, Eduardo Gomes Lima, Peter Karl Jacobsen, Louis Arnould, Simao Lottenberg, Renata Martins Maia, Livia Silva Conci, Tomas Minelli, Andrea Morato, Roberto Nery Dantas-Jr, Cesar Higa Nomura, Pedro Rissoli, Sergio Gianotti Pimentel, Carlos Vicente Serrano Junior
AIMS: To investigate the association between diabetic retinopathy (DR) and coronary artery disease (CAD) using coronary angiotomography (CCTA) and multimodal retinal imaging (MMRI) with ultra-widefield retinography and optical coherence tomography angiography and structural domain. METHODS: Single-center, cross-sectional, single-blind. Patients with diabetes who had undergone CCTA underwent MMRI. Uni and multivariate analysis were used to assess the association between CAD and DR and to identify variables independently associated with DR...
March 6, 2024: Journal of Diabetes and its Complications
https://read.qxmd.com/read/38463740/understanding-diabetic-cheiroarthropathy-a-focus-on-clinical-presentation
#35
Elijah M Persad-Paisley, Chanbin Lee, Reena A Bhatt
Diabetic cheiroarthropathy (DCA) is a relatively uncommon and underdiagnosed complication of poorly controlled diabetes. It is caused by non-enzymatic glycation of collagen that ultimately leads to microvascular damage and polyarticular stiffness. If diagnosed early, optimal management of serum glucose levels may lessen joint stiffness and prevent microvascular and macrovascular complications associated with diabetes mellitus. We review the case of a 55-year-old male with type 2 diabetes mellitus who was diagnosed with DCA after complaints of chronic joint stiffness and immobility...
March 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38458916/international-diabetes-federation-position-statement-on-the-1-hour-post-load-plasma-glucose-for-the-diagnosis-of-intermediate-hyperglycaemia-and-type-2-diabetes
#36
JOURNAL ARTICLE
Michael Bergman, Melania Manco, Ilhan Satman, Juliana Chan, Maria Inês Schmidt, Giorgio Sesti, Teresa Vanessa Fiorentino, Muhammad Abdul-Ghani, Ram Jagannathan, Pramod Kumar Thyparambil Aravindakshan, Rafael Gabriel, Viswanathan Mohan, Martin Buysschaert, Abdullah Bennakhi, Andre Pascal Kengne, Brenda Dorcely, Peter M Nilsson, Tiinamaija Tuomi, Tadej Battelino, Akhtar Hussain, Antonio Ceriello, Jaakko Tuomilehto
Many individuals with intermediate hyperglycaemia (IH), including impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT), as presently defined, will progress to type 2 diabetes (T2D). There is confirmatory evidence that T2D can be prevented by lifestyle modification and/or medications, in people with IGT diagnosed by 2-h plasma glucose (PG) during a 75-gram oral glucose tolerance test (OGTT). Over the last 40 years, a wealth of epidemiological data has confirmed the superior value of 1-h plasma glucose (PG) over fasting PG (FPG), glycated haemoglobin (HbA1c ) and 2-h PG in populations of different ethnicity, sex and age in predicting diabetes and associated complications including death...
March 6, 2024: Diabetes Research and Clinical Practice
https://read.qxmd.com/read/38456579/lifetime-and-10-year-cardiovascular-risk-prediction-in-individuals-with-type-1-diabetes-the-life-t1d-model
#37
JOURNAL ARTICLE
Marga A G Helmink, Steven H J Hageman, Björn Eliasson, Naveed Sattar, Frank L J Visseren, Jannick A N Dorresteijn, Katie Harris, Sanne A E Peters, Mark Woodward, Péter Szentkúti, Kurt Højlund, Jan Erik Henriksen, Henrik Toft Sørensen, Erik H Serné, Thomas T van Sloten, Reimar W Thomsen, Jan Westerink
AIMS: To develop and externally validate the LIFE-T1D model for the estimation of lifetime and 10-year risk of cardiovascular disease (CVD) in individuals with type 1 diabetes. MATERIALS AND METHODS: A sex-specific competing risk-adjusted Cox proportional hazards model was derived in individuals with type 1 diabetes without prior CVD from the Swedish National Diabetes Register (NDR), using age as the time axis. Predictors included age at diabetes onset, smoking status, body mass index, systolic blood pressure, glycated haemoglobin level, estimated glomerular filtration rate, non-high-density lipoprotein cholesterol, albuminuria and retinopathy...
March 8, 2024: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/38446483/use-of-diabetes-technologies-and-retinopathy-in-adults-with-type-1-diabetes
#38
JOURNAL ARTICLE
T Y Alvin Liu, Julia Shpigel, Fatima Khan, Kerry Smith, Laura Prichett, Roomasa Channa, Sarah Kanbour, Marissa Jones, Mohammed S Abusamaan, Aniket Sidhaye, Nestoras Mathioudakis, Risa M Wolf
IMPORTANCE: Diabetic retinopathy (DR) is a complication of diabetes that can lead to vision loss. Outcomes of continuous glucose monitoring (CGM) and insulin pump use in DR are not well understood. OBJECTIVE: To assess the use of CGM, insulin pump, or both, and DR and proliferative diabetic retinopathy (PDR) in adults with type 1 diabetes (T1D). DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study of adults with T1D in a tertiary diabetes center and ophthalmology center was conducted from 2013 to 2021, with data analysis performed from June 2022 to April 2023...
March 4, 2024: JAMA Network Open
https://read.qxmd.com/read/38445149/diabetic-foot-complications-in-saudi-arabia-a-retrospective-study
#39
JOURNAL ARTICLE
Sherif M Zaki, Dina S El Karsh, Tuleen M Faden, Leen T Almghamsi, Joud O Fathaldin, Omar A Alhazmi
REVIEW: A common chronic health problem among Saudi Arabians is diabetes mellitus (DM). One of the most serious complications of diabetes is diabetic foot (DMF). AIM: The objective of this study was to identify the most common complications that develop among patients with DMF. In addition, we conducted a demographic analysis of chronic diabetic complications related to DMF. MATERIAL AND METHODS: The study involved 100 DMF attending the Jeddah clinic of Dr Soliman Fakeeh Hospital...
February 2024: Curēus
https://read.qxmd.com/read/38438934/advances-in-secondary-prevention-mechanisms-of-macrovascular-complications-in-type-2-diabetes-mellitus-patients-a-comprehensive-review
#40
REVIEW
Huifang Guan, Jiaxing Tian, Ying Wang, Ping Niu, Yuxin Zhang, Yanjiao Zhang, Xinyi Fang, Runyu Miao, Ruiyang Yin, Xiaolin Tong
Type 2 diabetes mellitus (T2DM) poses a significant global health burden. This is particularly due to its macrovascular complications, such as coronary artery disease, peripheral vascular disease, and cerebrovascular disease, which have emerged as leading contributors to morbidity and mortality. This review comprehensively explores the pathophysiological mechanisms underlying these complications, protective strategies, and both existing and emerging secondary preventive measures. Furthermore, we delve into the applications of experimental models and methodologies in foundational research while also highlighting current research limitations and future directions...
March 4, 2024: European Journal of Medical Research
keyword
keyword
165572
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.